AIMS/HYPOTHESIS: SLC30A8 encodes a zinc transporter in the beta cell; individuals with a common missense variant (rs13266634; R325W) in SLC30A8 demonstrate a lower early insulin response to glucose and an increased risk of type 2 diabetes. We hypothesised that zinc supplementation may improve insulin secretion in a genotype-dependent manner. METHODS: We evaluated the early insulin response to glucose (using frequently sampled intravenous glucose tolerance testing) by R325W genotype before and after 14 days of supplementation with oral zinc acetate (50 mg elemental zinc) twice daily in healthy non-diabetic Amish individuals (N = 55). RESULTS: Individuals with RW/WW genotypes (n = 32) had the lowest insulin response to glucose at 5 and 10 min at baseline (vs RR homozygotes [n = 23]). After zinc supplementation, the RW/WW group experienced 15% and 14% increases in the insulin response to glucose at 5 and 10 min, respectively (p ≤ 0.04), and, compared with RR homozygotes, experienced a 26% (p = 0.04) increase in insulin at 5 min. We observed reciprocal decreases in proinsulin:insulin in the RW/WW (p = 0.002) vs RR group (p = 0.048), suggesting a genotype-specific improvement in insulin processing. CONCLUSIONS/ INTERPRETATION: Zinc supplementation appears to affect the early insulin response to glucose differentially by rs13266634 genotype and could be beneficial for diabetes prevention and/or treatment for some individuals based on SLC30A8 variation. TRIAL REGISTRATION: ClinicalTrials.gov NCT00981448.
AIMS/HYPOTHESIS: SLC30A8 encodes a zinc transporter in the beta cell; individuals with a common missense variant (rs13266634; R325W) in SLC30A8 demonstrate a lower early insulin response to glucose and an increased risk of type 2 diabetes. We hypothesised that zinc supplementation may improve insulin secretion in a genotype-dependent manner. METHODS: We evaluated the early insulin response to glucose (using frequently sampled intravenous glucose tolerance testing) by R325W genotype before and after 14 days of supplementation with oral zinc acetate (50 mg elemental zinc) twice daily in healthy non-diabetic Amish individuals (N = 55). RESULTS: Individuals with RW/WW genotypes (n = 32) had the lowest insulin response to glucose at 5 and 10 min at baseline (vs RR homozygotes [n = 23]). After zinc supplementation, the RW/WW group experienced 15% and 14% increases in the insulin response to glucose at 5 and 10 min, respectively (p ≤ 0.04), and, compared with RR homozygotes, experienced a 26% (p = 0.04) increase in insulin at 5 min. We observed reciprocal decreases in proinsulin:insulin in the RW/WW (p = 0.002) vs RR group (p = 0.048), suggesting a genotype-specific improvement in insulin processing. CONCLUSIONS/ INTERPRETATION: Zinc supplementation appears to affect the early insulin response to glucose differentially by rs13266634 genotype and could be beneficial for diabetes prevention and/or treatment for some individuals based on SLC30A8 variation. TRIAL REGISTRATION: ClinicalTrials.gov NCT00981448.
Authors: I Kim; E S Kang; Y S Yim; S J Ko; S-H Jeong; J H Rim; Y S Kim; C W Ahn; B S Cha; H C Lee; C H Kim Journal: Pharmacogenomics J Date: 2010-03-30 Impact factor: 3.550
Authors: N Wijesekara; F F Dai; A B Hardy; P R Giglou; A Bhattacharjee; V Koshkin; F Chimienti; H Y Gaisano; G A Rutter; M B Wheeler Journal: Diabetologia Date: 2010-04-28 Impact factor: 10.122
Authors: Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell Journal: Science Date: 2007-04-26 Impact factor: 47.728
Authors: Lynley D Pound; Suparna A Sarkar; Stéphane Cauchi; Yingda Wang; James K Oeser; Catherine E Lee; Philippe Froguel; John C Hutton; Richard M O'Brien Journal: J Mol Endocrinol Date: 2011-09-30 Impact factor: 5.098
Authors: Stavroula Kanoni; Jennifer A Nettleton; Marie-France Hivert; Zheng Ye; Frank J A van Rooij; Dmitry Shungin; Emily Sonestedt; Julius S Ngwa; Mary K Wojczynski; Rozenn N Lemaitre; Stefan Gustafsson; Jennifer S Anderson; Toshiko Tanaka; George Hindy; Georgia Saylor; Frida Renstrom; Amanda J Bennett; Cornelia M van Duijn; Jose C Florez; Caroline S Fox; Albert Hofman; Ron C Hoogeveen; Denise K Houston; Frank B Hu; Paul F Jacques; Ingegerd Johansson; Lars Lind; Yongmei Liu; Nicola McKeown; Jose Ordovas; James S Pankow; Eric J G Sijbrands; Ann-Christine Syvänen; André G Uitterlinden; Mary Yannakoulia; M Carola Zillikens; Nick J Wareham; Inga Prokopenko; Stefania Bandinelli; Nita G Forouhi; L Adrienne Cupples; Ruth J Loos; Goran Hallmans; Josée Dupuis; Claudia Langenberg; Luigi Ferrucci; Stephen B Kritchevsky; Mark I McCarthy; Erik Ingelsson; Ingrid B Borecki; Jacqueline C M Witteman; Marju Orho-Melander; David S Siscovick; James B Meigs; Paul W Franks; George V Dedoussis Journal: Diabetes Date: 2011-08-01 Impact factor: 9.461
Authors: Kathleen A Jablonski; Jarred B McAteer; Paul I W de Bakker; Paul W Franks; Toni I Pollin; Robert L Hanson; Richa Saxena; Sarah Fowler; Alan R Shuldiner; William C Knowler; David Altshuler; Jose C Florez Journal: Diabetes Date: 2010-08-03 Impact factor: 9.461
Authors: Laura J Corbin; Vanessa Y Tan; David A Hughes; Kaitlin H Wade; Dirk S Paul; Katherine E Tansey; Frances Butcher; Frank Dudbridge; Joanna M Howson; Momodou W Jallow; Catherine John; Nathalie Kingston; Cecilia M Lindgren; Michael O'Donavan; Stephen O'Rahilly; Michael J Owen; Colin N A Palmer; Ewan R Pearson; Robert A Scott; David A van Heel; John Whittaker; Tim Frayling; Martin D Tobin; Louise V Wain; George Davey Smith; David M Evans; Fredrik Karpe; Mark I McCarthy; John Danesh; Paul W Franks; Nicholas J Timpson Journal: Nat Commun Date: 2018-02-19 Impact factor: 14.919